Dopamine (DA) modulates glutamate neurotransmission in the striatum. Abnormal DA modulation has been implicated in neurological and psychiatric disorders. The development of DA transporter knock-down (DAT-KD) mice has permitted modeling of these disorders and has shed new light on DA modulation. DAT-KD mice exhibit increased extracellular DA, hyperactivity and alterations in habituation. We used whole-cell patch clamp recordings from visually identified striatal neurons in slices to examine the effects of DAT-KD on corticostriatal transmission. Electrophysiological recordings from medium-sized spiny neurons in the dorsal striatum revealed alterations in both amplitude and frequency, of spontaneous glutamate receptor-mediated synaptic currents in cells from DAT-KD mice. Furthermore, kinetic analyses revealed that these currents had shorter half-amplitude durations and faster decay times. In contrast, GABA receptor-mediated synaptic currents were not altered. Striatal neurons from DAT-KD mice also responded differently to amphetamine, cocaine, and DA D2 receptor agonists or antagonists compared to wildtype (WT) littermate controls. In WTs amphetamine and cocaine reduced the frequency of spontaneous glutamate currents and these effects appeared to be mediated by activation of D2 receptors. In contrast, in DAT-KD mice either no changes or small increases in frequency occurred. D2 receptor agonists or antagonists also had opposing effects in WT and DAT-KD mice. Together, these results indicate that chronically increased extracellular DA produces long-lasting changes in corticostriatal communication that may be mediated by changes in D2 receptor function. These findings have implications for understanding mechanisms underlying attention deficit hyperactivity disorder and Tourette's syndrome and may provide insights into novel therapeutic approaches.
Introduction
Abnormal dopamine (DA) transmission in the basal ganglia and cerebral cortex has been implicated in a number of neurological and psychiatric disorders such as Parkinson's disease, schizophrenia, Tourette's syndrome, and attention deficit hyperactivity disorder (ADHD) (reviewed in Albin and Mink 2006; Nieoullon and Coquerel 2003; Seamans and Yang 2004; Swanson et al. 1998) . The DA transporter (DAT), a membrane protein that recycles released DA into presynaptic terminals (Jones et al. 1998a) , plays a key role in altered DA transmission.
Genetic studies in humans have demonstrated a close linkage of the DAT gene and ADHD (Cook et al. 1995; Gill et al. 1997; Waldman et al. 1998) . DAT is also the target of psychostimulants, a common treatment for ADHD (reviewed in Madras et al. 2005 ).
The generation of mice with targeted deletion of the DAT gene has allowed a better understanding of DAT function (reviewed in Chen and Zhuang 2003) . DAT knock-out mice are hyperdopaminergic and display hyperactivity and memory deficits (Giros et al. 1996) . However, these animals also show growth defects and pituitary hypoplasia (Bosse et al. 1997 ). More recently, a DAT knock-down (KD) mouse with decreased expression of DAT (~10% of wildtype level) has been developed (Zhuang et al. 2001) . These mice are also hyperdopaminergic and hyperactive and display enhanced motivation for food reward (Cagniard et al. 2006; Pecina et al. 2003; Yin et al. 2006 ). However, they do not show growth abnormalities (Zhuang et al. 2001 ).
These attributes make the DAT-KD mice a potentially more suitable animal model of ADHD.
Several mouse models of basal ganglia diseases show alterations in synaptic transmission along the corticostriatal pathway. For example, we have shown reduced spontaneous and evoked glutamate synaptic activity in mouse models of Huntington's disease (Cepeda et al. 2003; Klapstein et al. 2001) . Some similar changes were observed in a mouse model of Parkinson's Page 3 of 45 4 disease (Goldberg et al. 2003) . Interestingly, in these mouse models DA transmission is also significantly altered (Goldberg et al. 2003; Johnson et al. 2006) .
The aim of the present study was to examine potential alterations in spontaneous excitatory synaptic currents (sEPSCs) in striatal medium-sized spiny neurons (MSSNs) in DAT-KD mice. Because DA modulates responses evoked by activation of glutamate receptors (Cepeda et al. 1993) , we hypothesized that abnormal chronic exposure to high levels of DA would produce alterations in synaptic activity along the corticostriatal pathway. We also examined the effects of drugs that alter DA function, some of which are used to treat ADHD.
Material and Methods
All experimental procedures were carried out in accordance with the USPHS Guide for Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at UCLA. Experiments were conducted on DAT-KD (n=35) and age-matched littermate controls (WT, n=25) . Average ages were 69±1.7 and 68±2.1 days for DAT-KD and WT animals respectively and did not differ between the two groups.
After sacrificing the brains were dissected and immediately placed in oxygenated ice cold low-calcium artificial cerebrospinal fluid (ACSF) containing (in mM) NaCl, 130; NaH 2 PO 4 , 1.25; NaHCO 3 , 26; MgCl 2 , 5; CaCl 2 , 1 and glucose, 10. The hemispheres were separated and 350 µm coronal slices were cut and transferred to an incubating chamber containing ACSF (with 2 mM CaCl 2 and 2 mM MgCl 2 ) oxygenated with 95% O 2 -5% CO 2 , pH 7.2-7.4, 290-310 mOsm, 25±2°C. After 1 h slices were placed on the stage of an upright Olympus microscope (BX51), Passive membrane properties of MSSNs were determined in voltage clamp mode by applying a depolarizing step voltage command (10 mV) and using the membrane test function integrated in the pClamp8 software (Axon Instruments, Foster City, CA). This function reports membrane capacitance (in pF), input resistance (in MO) and time constant (in msec). The time constant was obtained from a single exponential fit to the decay of the capacitive transients. In addition, a separate group of neurons from DAT-KD and WT mice were recorded in current clamp mode using patch electrodes containing (in mM): K-gluconate 140, HEPES 10, MgCl 2 2, CaCl 2 0.1, EGTA 1.1, and K 2 ATP 2 (pH 7. osmolarity, [280] [281] [282] [283] [284] [285] [286] [287] [288] [289] [290] . Resting membrane potential (RMP), action potential parameters and responses to depolarizing and hyperpolarizing square wave current pulses were examined.
Spontaneous postsynaptic currents were recorded in standard artificial cerebrospinal fluid (ACSF) composed of the following (in mM): NaCl 130, NaHCO 3 26, KCl 3, MgCl 2 2, NaHPO 4 1.25, CaCl 2 2, glucose 10 (pH 7.2-7.4, osmolarity 290-300 mOsm). Cells were held at -70 mV to minimize the contribution of GABA A receptors and that of voltage-gated conductances. In Page 5 of 45 6 addition, in most experiments bicuculline methiodide (BIC, 10 SM, Tocris Ellisville, MO) also was added to block the contribution of spontaneous currents mediated by activation of GABA A receptors. After characterizing the basic membrane properties of the neuron, sEPSCs were recorded for variable periods of time (usually 3-6 min). The membrane current was filtered at 1 kHz and digitized at 200 Ss using Clampex (gap free mode) (Axon Instruments, Inc.; Foster City, CA). In some cells tetrodotoxin (TTX, 1 SM, CalBiochem, La Jolla, CA) was added to isolate miniature (m) EPSCs, events that were not dependent on presynaptic action potentials.
Drugs affecting DA receptor function, D-amphetamine (25 SM), cocaine (10 SM), quinpirole (10 SM), sulpiride (10 SM), and SCH 23390 (20 SM, a D1 receptor antagonist), or acetylcholine receptor function, atropine sulfate (1 SM, a muscarinic antagonist) and muscarine (10 SM) were purchased from Sigma-Aldrich, Inc. (St. Louis, MO). They were prepared as stock solutions in double-distilled water and diluted to their final concentration before each experiment. Sulpiride was freshly made for each experiment. All drugs were applied in the bath.
Spontaneous synaptic events were analyzed off-line using the Mini Analysis Program (Jaejin Software, Leonia, NJ). This software was used to calculate EPSC frequency, amplitude of events, and to construct amplitude-frequency histograms. The threshold amplitude for the detection of an event was adjusted to at least 2 times above root mean square noise level [generally 2-3 pA at -70 mV, 4-5 pA at +20 mV, and about 10 pA when 4-aminopyridine (4-AP, Sigma-Aldrich, Inc., St. Louis, MO) was in the bath]. Frequencies were expressed as number of events per second (Hz). EPSC kinetic analysis was performed using the Mini Analysis Program.
Events with peak amplitudes between 6-50 pA were grouped, aligned by half-rise time and averaged to obtain rise times, decay times and durations at half-amplitude. Events with complex 7 peaks were eliminated from this analysis. First and second order exponential curves were fit with a maximum of 5000 iterations.
Values in the figures and text are presented as mean±standard error (SE). Differences in mean currents at various holding voltages were assessed with two-way analyses of variance with one repeated measure followed by multiple comparisons using Bonferroni t-tests. Student's ttests alone were used when only two group means were compared. Differences between means were considered statistically significant if p<0.05.
Results
Based on somatic size and typical membrane properties (Cepeda et al. 1998a 8 current pulses were similar in neurons from DAT-KD and WT animals ( Fig. 1 ). All cells recorded demonstrated inward rectification in the hyperpolarizing direction, a defining feature of MSSNs (Fig. 1) .
DAT-KD mice exhibit a greater frequency of intermediate amplitude sEPSCs
Spontaneous synaptic currents were recorded in voltage clamp (Cs-methanesulfonate in the patch pipette) at a holding potential of -70 mV in standard ACSF ( Fig. 2A) . At this potential all spontaneous currents were inward and mostly reflected non-NMDA receptor activation by glutamate. The frequency of these currents was not significantly changed by BIC (Fig. 2B) .
Application of the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM) in a subset of recorded neurons (n=30) completely blocked spontaneous synaptic currents, indicating they were mediated predominantly by activation of AMPA-kainate receptors (Fig. 2C ). The mean frequency of spontaneous synaptic currents was 2.06±0.13 Hz in neurons from WTs (n=77 cells) and 2.34±0.18 Hz in neurons from DAT-KDs (n=82 cells) ( 
Larger-amplitude currents in DAT-KD mice are dependent on action potentials
As the presence of large synaptic events could be a function of increased firing of presynaptic neurons or of increased multiquantal release, we next tested whether presynaptic cell firing contributed to increases in the amplitude of spontaneous synaptic activity by applying BIC to block GABA A -receptor mediated currents and TTX (1 µM) to block the activation of voltagegated Na + channels and to determine the percentage of spontaneous synaptic currents that are independent of action potentials (mEPSCs). Neurons were held at -70 mV. TTX significantly decreased the frequency of spontaneous postsynaptic currents in all recorded MSSNs from WTs and DAT-KDs (Fig. 4A-4C ). The mean frequencies of mEPSCs after TTX were not significantly different [1.28±0.23 Hz (n=9) versus 1.52±0.17 Hz (n=24), in cells from WTs and DAT-KDs, respectively]. About 80% of sEPSCs in WTs and about 75% in DAT-KDs were TTX-resistant (Fig. 4D) . While there were significant differences between the cumulative amplitude histograms from WT and DA-KD cells before TTX (p<0.05-0.01, 6-12 pA amplitude bins, Fig. 4F ), after TTX these differences no longer occurred (Fig. 4F, right graph) . Cumulative frequency distributions of inter-event interval (a measure of release probability) demonstrated that the shift to the left, indicative of proportionately more shorter inter-event intervals in cells from DAT-KD Page 10 of 45 mice, was reduced in the presence of TTX (Fig. 4G) . Since the overall frequency of mEPSCs was not different, larger amplitude events in DAT-KD mice were likely dependent on action potential generation. Interestingly, the kinetic properties of mEPSCs also were similar in cells from WT and DAT-KD mice (Fig. 4E) , suggesting that the faster kinetic properties observed in the absence of TTX were due primarily to the occurrence of larger synaptic currents.
Cholinergic interneurons are not responsible for the increased frequency of intermediateamplitude currents in DAT-KD mice
To examine the possibility that differential tonic firing of cholinergic interneurons may have contributed to the differences in sEPSCs in MSSNs from DAT-KD and WT mice, we recorded the activity of visually and electrophysiologically identified large, putative cholinergic interneurons (n=4 in WT and n=5 in DAT-KD). These interneurons have been shown to fire spontaneously in slices (Bennet and Wilson, 1999) . Indeed, in our recording conditions we confirmed spontaneous firing. However, no difference in firing rates was observed (2.5±0.7 Hz in WT and 2.4±0.5 Hz in DAT-KD). We also examined the effects of muscarine (10 µM, n=9 and 11 cells from WT and DAT-KD mice, respectively) or the muscarinic antagonist atropine (1 µM, n=11 and 12 cells from WT and DAT-KD mice, respectively) on the frequency of sEPSCs in MSSNs from WT and DAT-KD mice. Muscarine produced almost no change in frequency (-4±4.6% change in WT versus -4±6.0% change in DAT-KD cells). Atropine produced a small non-statistically significant decrease in both groups (-7±5% change in WT versus -13±6% change in DAT-KD cells). Thus, cholinergic inputs have a relatively minor contribution to the observed changes in sEPSCs.
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The amplitude but not the frequency of spontaneous NMDA currents is changed in DAT-
KD mice
One next question was whether or not a difference in NMDA receptor-mediated currents between the two groups also existed. To answer this we isolated NMDA currents by modifying the ACSF solution. First Mg 2+ was eliminated to remove the voltage-dependence of activation of NMDA receptors and then BIC (10 µM) was added to block GABA A receptor-mediated currents. DAT-KDs; p>0.05; Fig. 5F left] . Amplitude-frequency histograms demonstrated that the slightly lower average frequency in neurons from DAT-KDs was due to a significantly reduced frequency of smaller-amplitude events (20-30 pA, p<0.03; Fig. 5F right) . In contrast, the frequency of large amplitude NMDA events (>40 pA) induced by 4-AP application did not differ between cells from WTs and DAT-KDs (Fig. 5F right) . This may be due to the fact that 4-AP produced a generalized increase in large-amplitude events in both groups of mice.
Spontaneous GABAergic synaptic activity is not altered in DAT-KD mice
GABA is the principal inhibitory neurotransmitter in the basal ganglia and is the transmitter used by most neurons of the striatum, including the MSSNs and a variety of inhibitory interneurons (Czubayko and Plenz 2002; Koos and Tepper 1999; Oertel and Mugnaini 1984; Venance et al. 2004 ). Therefore, we also examined spontaneous currents mediated by activation of GABA A receptors in neurons from DAT-KD mice. In standard ACSF cells were held at +20 mV to increase the driving force of GABA A synaptic currents (in our experimental conditions the equilibrium potential for GABA A currents is around -60 mV). At this holding potential, spontaneous synaptic currents were outward (Fig. 6A ) and glutamate currents did not contribute as application of BIC (10 µM) completely abolished all synaptic activity (Fig. 6B ).
WT and DAT-KD cells exhibited approximately equal mean frequencies of spontaneous GABA A receptor-mediated outward currents [Fig. 6C, 3 .25±0.6 Hz in WTs (n=13) and 3.66±1.0 Hz in DAT-KDs (n=15)]. The difference in mean frequencies between cells from WT and DAT-KD animals was not statistically significant. Amplitude-frequency histograms showed that all cells from DAT-KD mice exhibited small increases in frequency of events at all amplitudes but again Page 13 of 45 these increases were not statistically significant (Fig. 6D) . These results indicate that DAT-KD mainly affects glutamate receptor-mediated currents.
Effects of Amphetamine and Cocaine
DAT-KD mice only express ~10% of the DAT compared to WT levels, and their ability to clear released DA decreases, which results in elevated DA tissue levels (~50%) as measured by in vivo microdialysis (Zhuang et al. 2001) . In order to examine whether the high extracellular DA concentration would affect the sensitivity to pharmacological manipulations of the DA system in DAT-KD mice, we bath applied amphetamine (APT) (25 µM), an indirect agonist that increases DA release and prevents DA reuptake (Jones et al. 1998b) . The data examining effects of APT, [as well as cocaine (COC), quinpirole and sulpiride] were analyzed with a two way ANOVA and the interaction term between genotype and drug application was statistically significant. Subsequent changes in frequency were assessed with post-hoc t-tests (Bonferroni).
After applying APT, the frequency of EPSCs in MSSNs was significantly reduced in WT cells (7%) was not statistically significant. COC application also did not affect the amplitude of the spontaneous currents. Taken together, these results suggest that in DAT-KD mice the ability of DA to modulate glutamate release at the corticostriatal pathway is impaired.
Role of DA Receptors
One possible explanation for the changes in sEPSCs in WTs is that the increase in DA release caused by APT and COC activated presynaptic D2 receptors, which can attenuate glutamate release (Kornhuber and Kornhuber 1986; Rowlands and Roberts 1980; Yamamoto and Davy 1992), therefore reducing the frequency of sEPSCs (Cepeda et al. 2001; Flores-Hernández et al. 1997) . The observation that the frequency of events was not significantly altered in DAT-KD mice implied either that these animals were hyposensitive to DA or had a D2 receptor dysfunction. Our laboratory has reported previously that the modulatory actions of DA in the striatum are a function of the excitatory amino acid receptor as well as the specific DA receptor subtype activated. DA, via activation of D1 receptors, potentiates responses mediated by activation of NMDA receptors, whereas activation of D2 receptors attenuates responses mediated by activation of non-NMDA receptors (Cepeda et al. 1993; Levine et al. 1996) . Since DAT-KD mice have lost the ability of DA to modulate non-NMDA receptor-mediated spontaneous synaptic currents, we hypothesized that D2 receptors might be dysfunctional in DAT-KDs. To more directly test this hypothesis, we applied quinpirole (10 µM), a selective D2 receptor agonist 
Discussion
The present study demonstrated a series of changes in spontaneous glutamatergic synaptic activity in the striatum of DAT-KD mice. In contrast, GABAergic synaptic activity did Page 16 of 45 not appear to be affected by the mutation. Although the overall frequency of sEPSCs in MSSNs was similar in DAT-KD and WT mice, the frequency of intermediate-amplitude events was significantly increased in cells from DAT-KD mice. Alterations in the kinetic properties of EPSCs also were observed. Furthermore, drugs that manipulate the DA system like APT and COC had minimal effects on sEPSC frequency in DAT-KD mice. Finally, the ability of a DA D2 receptor agonist and antagonist to modulate excitatory transmission along the corticostriatal pathway was severely compromised in DAT-KD animals, suggesting alterations in DA receptor function. These deficits could be caused by down-regulation of DA D2 receptors due to increased DA tone in mutant animals (Dumartin et al. 2000; Giros et al. 1996; Zhuang et al. 2001 ). The alterations are less likely due to deceases in the levels of D2 receptor expression as this possibility was ruled out by a previous study (Zhuang et al. 2001) .
It is well established that DA modulates glutamatergic transmission at the pre-and postsynaptic levels in striatum and cerebral cortex (Bamford et al. 2004b; Cepeda et al. 1993 Cepeda et al. , 1998 Cepeda et al. , 2001 Knock-down of DAT produces an elevation in tissue DA levels. DA release is decreased by about 25% which is probably due to deficient recycling, and clearance is markedly decreased (Zhuang et al., 2001) . Tissue DA levels are elevated by about 50% as measured by in vivo microdialysis. These changes in extracellular DA and its dynamics will have long-term effects of DA receptors which may explain some of the electrophysiological alterations observed in the present study as well as the effects of DA modulating drugs like APT and COC. (Cepeda et al., 1993; Hernández-Echeagaray et al., 2006) . Although an early study suggested that the presynaptic modulation of glutamate transmission required a state of D2 receptor supersensitivity (Calabresi et al. 1992) , others found that this modulation could occur in physiological conditions in a significant number of striatal neurons (Bamford et al. 2004b; Cepeda et al. 1994; Flores-Hernández et al. 1997; Hsu et al. 1995) . In contrast, another study found clear modulation in the ventral but not in the dorsal striatum (Nicola and Malenka, 1998).
However, in this study very young animals were used and it is likely that effects were not seen Page 18 of 45 because DA modulation in this region matures more slowly. Recently it was shown that endocannabinoids mediate some of the presynaptic effects of D2 receptor activation (Kreitzer and Malenka, 2005; Yin and Lovinger, 2006) . However, retrograde endocannabinoid modulation occurs only with strong, high frequency stimulation (Yin and Lovinger, 2006) . In our recordings of sEPSCs it is less likely that endocannabinoid receptors play a significant role. Furthermore, animals with deletion of D2 receptors show facilitation of glutamate release at corticostriatal synapses, demonstrating a critical role of presynaptic D2 receptors (Cepeda et al. 2001 ).
Here we demonstrate that in striatal neurons from DAT-KD mice intermediate-amplitude sEPSCs occur more frequently in DAT-KD compared to WT animals and that a proportion of these currents are dependent on action potentials. In conditions of chronic hyperdopaminergia there appears to be a marked alteration of presynaptic D2 receptor function. In normal conditions presynaptic D2 receptors serve as a filter of corticostriatal signaling by dampening glutamate release and reducing the occurrence of intermediate amplitude synaptic events (Bamford et al. 2004b; Cepeda et al. 2001; Flores-Hernández et al. 1997) . Reduced function of these receptors would allow more glutamate release along the corticostriatal pathway and proportionately more of these events occur and proportionately fewer small amplitude events occur (6-10 pA bins).
This down-regulation was also manifested by reduced effects of drugs that increase striatal DA concentration such as APT and COC. Finally, increased frequency of intermediate amplitude events could have been further facilitated by down-regulation of postsynaptic D2 receptors (Levine et al. 1996) .
Alterations in the frequency of sEPSCs were less pronounced than changes in amplitude.
This could be a consequence of expression of different DA receptor isoforms. Thus, it has been shown recently that the presynaptic modulation of glutamate transmission in the corticostriatal Page 19 of 45 20 pathway depends on the D2 short isoform (Centonze et al. 2004 ). Interestingly, this study also showed that GABAergic transmission can be modulated by both isoforms, which could explain why we found no changes in GABAergic activity in DAT-KD mice.
NMDA receptor-mediated responses were also affected. A shift in the amplitudefrequency distribution towards fewer small amplitude events occurred in mutant mice. At present it is difficult to know what caused this shift. It is possible that the mutation also affected D1 receptors and this facilitated NMDA currents. However, because increased DA tone may also down-regulate D1 receptors (Dumartin et al. 2000; Zhuang et al. 2001) , this possibility seems unlikely. Another possibility is that down-regulation of D2 receptors facilitates NMDA currents.
We have proposed previously that D2 receptors may function to counter excessive enhancement of NMDA responses by D1 receptors (Cepeda et al. 1998a, b; Flores-Hernández et al. 2002) . If increase in DA function is hypothesized such as ADHD and Tourette's syndrome. In fact, it could be speculated that motor hyperactivity is due to an alteration of glutamate currents.
Reduced D2 function could leave a complement of corticostriatal signals unchecked, allowing for unfiltered inputs to reach the striatum. Attention could also be affected as increased glutamatergic function could translate into changes in motivational value as well as saliency of stimuli (Pecina et al., 2003) . In hyperdopaminergic mice, everything would appear salient and deserving of attention. This means that therapeutic trials of drugs used to treat ADHD or Tourette's syndrome should not only concentrate on the dysregulation of the DA system, but should also consider changes in other neurotransmitter systems. For example, it has been shown that the calming effect of psychostimulants in DAT-KO mice is not mediated by a reduction in DA levels, but by activation of the serotoninergic system (Gainetdinov et al., 1999) . It has been shown also that the hyperactivity of DAT-KO mice can be further enhanced by NMDA receptor blockers. In contrast, drugs that increase glutamatergic transmission suppress the hyperactivity of DAT-KO mice (Gainetdinov et al., 2001) . A potential mechanism of these effects appears to involve modulation of serotoninergic transmission in the frontal cortex (Gainetdinov et al., 2001; Sotnikova et al., 2006) . This implies that the final outcome of drugs used to treat disorders of DA function depends on their actions on multiple neurotransmitter systems affecting cortical neurons, the flow of information along the corticostriatal pathway, and the specific subsets of striatal neurons activated by those inputs. Evidently, more studies have to be performed to better understand these effects. Mouse models of hyperdopaminergia provide new ways to evaluate the mechanisms and potential benefits of drugs used to treat disorders caused by chronic increases of DA.
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